Coronary angiography after cardiac arrest: Rationale and design of the COACT trial

Jorrit S Lemkes1, Gladys N Janssens1, Heleen M Oudemans-van Straaten2

  • 1Department of Cardiology, VU University Medical Centre, Amsterdam, the Netherlands.

American Heart Journal
|September 24, 2016
PubMed

Insights

Immediate coronary angiography and intervention after cardiac arrest without STEMI may improve survival. This study investigates if early invasive procedures enhance 90-day survival in these critical patients.

Area of Science:

  • Cardiology
  • Critical Care Medicine
  • Interventional Cardiology

Background:

  • Ischemic heart disease frequently leads to out-of-hospital cardiac arrest.
  • The benefit of immediate coronary angiography (CAG) and percutaneous coronary intervention (PCI) in cardiac arrest survivors without ST-segment elevation myocardial infarction (STEMI) is uncertain.

Purpose of the Study:

  • To test the hypothesis that immediate CAG and PCI improve 90-day survival in post-cardiac arrest patients without STEMI.
  • To evaluate the impact of an early invasive coronary strategy on key clinical outcomes.

Main Methods:

  • A prospective, multicenter, randomized controlled trial involving 552 patients.
  • Patients without STEMI after restoration of spontaneous circulation were randomized to immediate CAG/PCI (within 2 hours) or delayed procedures.
  • The primary endpoint was 90-day survival, with secondary endpoints including neurological status and organ injury.

Main Results:

  • The study is designed to evaluate the effect of immediate CAG and PCI.
  • Results regarding the primary endpoint of 90-day survival are pending.

Conclusions:

  • The COACT trial will determine the efficacy of an immediate invasive coronary strategy in post-cardiac arrest patients without STEMI.
  • Findings will guide clinical practice regarding the timing of cardiac interventions in this patient population.
Abstract

Related Concept Videos

Cardiopulmonary Resuscitation IV: Pharmacological Management01:25

Cardiopulmonary Resuscitation IV: Pharmacological Management

Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
1.2K
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
376
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
369
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
359